CREATION OF PHYCO-BIOTECH25 February 2011
Phyco-Biotech Laboratories founded by M.G. GAY, Dr. N. JOUY, and Dr. J.-C. BACCOU First activity: Research and Development in Biotechnology Expertise: extraction and purification of phycobiliproteins Research collaborations with INSERM, University of Montpellier, Faculty of Sciences of Montpellier, INRA Obtaining the JEI status (Young Innovative Company) for the R&D work carried out.
LABELS AND RESEARCH13 September 2012
Expansion of the range of natural fluorescent labels in precipitated form Beginning of Research and Development on the enrichment of Spirulina in trace elements Implementation of a PhD thesis with Dr. Joris VIDE.
STUDY RESULTS18 September 2013
Obtaining the eligibility of the Research Tax Credit Publications of the results of scientific studies demonstrating the benefits of bioavailable trace elements (organic form) on animal models (hypertensive Hamster and Rat SHR) Marketing of lyophilized natural fluorescent labels.
ACTIVITY DIVERSIFICATION28 January 2014
R&D in the pharmaceutical industry. Spirulina production enriched in trace elements (Iron, Silicon, Selenium). Creation of a range of natural food supplements for therapeutic purposes.
PATENT SUBMISSION8 April 2015
Phyco-Biotech Laboratories file two patents: a patent for therapeutic applications for Bioavailable Silicon and a patent for bioavailable silicon-enrichment technology.
ENLARGEMENTS AND EXTENSION1 January 2016
Beginning of research work on cosmetic products. Extension of patents for Europe. Enlargement of the range of fluorescent labels.
ICEPS AND PHYCOCYANIN27 March 2017
Phyco-Biotech Laboratories win the 2017 ICEPS Award: Non-Drug Interventions. Production of lyophilized phycocyanin at (purity index: 3.7, i.e. 93% purity).
CLINICAL TRIAL12 June 2018
Beginning of a clinical study on humans in phase 3 that aims to demonstrate the benefits of bioavailable silicon from Phyco-Biotech Laboratories on cardiovascular diseases. Our R&D collaborations